Who are Permethrin 1%'s main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Lamotrigine (drug), Lamotrigine Generic "A", Pregabalin and Oxcarbazepine, Carbamazepine (Tegretol), intravenous lidocaine (IVL), Chloroprocaine Injection.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/permethrin-1.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-13 · How we verify

Permethrin 1% — Competitive Intelligence Brief

Permethrin 1% (Permethrin 1%) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: pyrethroid. Area: Public Health.

phase 3 pyrethroid Voltage-gated sodium channels Public Health Small molecule Live · refreshed every 30 min

Target snapshot

Permethrin 1% (Permethrin 1%) — ParaPRO LLC. Permethrin 1% acts as an acaricide and insecticide by disrupting the nervous system of insects and arachnids.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Permethrin 1% TARGET	Permethrin 1%	ParaPRO LLC	phase 3	pyrethroid	Voltage-gated sodium channels
Lamotrigine (drug)	Lamotrigine (drug)	MaineHealth	marketed	Anticonvulsant / Antiepileptic drug	Voltage-gated sodium channels; glutamate release inhibition
Lamotrigine Generic "A"	Lamotrigine Generic "A"	University of Cincinnati	marketed	Anticonvulsant / Mood stabilizer	Voltage-gated sodium channels; glutamate release inhibition
Pregabalin and Oxcarbazepine	Pregabalin and Oxcarbazepine	Ju Seok Ryu	marketed	Anticonvulsant combination; Gabapentinoid and aromatic antiepileptic drug	Alpha-2-delta calcium channel subunit (pregabalin); voltage-gated sodium channels (oxcarbazepine)
Carbamazepine (Tegretol)	Carbamazepine (Tegretol)	Korean Epilepsy Society	marketed	Anticonvulsant; sodium channel blocker	Voltage-gated sodium channels
intravenous lidocaine (IVL)	intravenous lidocaine (IVL)	Ciusss de L'Est de l'Île de Montréal	marketed	Local anesthetic; Class IB antiarrhythmic	Voltage-gated sodium channels
Chloroprocaine Injection	Chloroprocaine Injection	Nova Scotia Health Authority	marketed	Local anesthetic (ester)	Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (pyrethroid class)

ParaPRO LLC · 1 drug in this class
Sun Pharmaceutical Industries, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Permethrin 1% — Competitive Intelligence Brief. https://druglandscape.com/ci/permethrin-1. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab